Phase I Study of an Oncofetal Antigen Multi-Peptide Immunotherapy in Subjects With Hematologic Cancer

Clinical trial NCT02240537 · UNKNOWN

Trial details

NCT number: NCT02240537
Sponsor: Benovus Bio, Inc.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myelogenous Leukemia (AML)Multiple Myeloma (MM)Myelodysplastic Syndrome (MDS)Smoldering Multiple Myeloma (sMM)

Start date: 2015-01-01
Primary completion: 2016-12-01
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.